Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Disaggregation Of Revenue [Line Items]
Revenues	$ 11,461	$ 13,511	$ 29,845	$ 27,766
Scilex Pharmaceuticals Inc. Product Sales
Disaggregation Of Revenue [Line Items]
Revenues	7,926	7,802	14,738	14,788
Sorrento Therapeutics, Inc. product revenues
Disaggregation Of Revenue [Line Items]
Revenues	665	52	3,844	89
Net Product Revenues
Disaggregation Of Revenue [Line Items]
Revenues	8,591	7,854	18,582	14,877
Concortis Biosystems Corporation
Disaggregation Of Revenue [Line Items]
Revenues	1,983	3,468	6,617	8,930
Bioserv Corporation
Disaggregation Of Revenue [Line Items]
Revenues	592	1,382	1,467	2,581
Other Service Revenues
Disaggregation Of Revenue [Line Items]
Revenues	295	807	3,179	1,378
Service Revenues
Disaggregation Of Revenue [Line Items]
Revenues	$ 2,870	$ 5,657	$ 11,263	$ 12,889